Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Stryker buys Gaymar Industries for $150 million

August 25, 2010 9:45 am | by The Associated Press | News | Comments

Medical device maker Stryker Corp. said Wednesday it agreed to buy privately held Gaymar Industries for $150 million in cash.The boards of both companies have approved the sale, which is expected to close by Oct. 1.Stryker, which makes hip and knee implants and other orthopedic devices and...

Career Direction for Children – Preparing for Sustainable Careers in Growth Industries

August 25, 2010 9:38 am | by Society of Manufacturing Engineers | News | Comments

DEARBORN, Mich., August 24, 2010 - Children are fascinated by things their parents no longer see, solve problems with simple solutions, and if left to explore, are naturally exhilarated by learning. The first step in providing career direction for children is making sure they have simple...

Brain imaging gives new insight into mental disorders

August 25, 2010 9:36 am | by Baylor College of Medicine | News | Comments

A new kind of psychiatry built on objective measures derived from functional magnetic resonance imaging (or fMRI) of the brain performed while patients play economic games could provide new insight into the diagnosis and, eventually, treatment of mental disorders, said researchers from...

TOPICS:
Advertisement

AACR Supports NIH Stem Cell Research

August 25, 2010 9:34 am | by AACR | News | Comments

PHILADELPHIA - The American Association for Cancer Research (AACR), the world's oldest and largest cancer research organization, reiterates its support for the responsible conduct of human embryonic stem cell research that, up until this week, was funded by the National Institutes of...

TOPICS:

MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient

August 25, 2010 9:30 am | by U.S. Food & Drug Administration | News | Comments

UPDATED 08/25/2010. Product marketed as dietary supplement contains undeclared Aminotadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

TOPICS:

Advanced CNC Machining Allows for Dramatic Improvements in R & D and Production Output for Surgical Toolmaker

August 25, 2010 8:58 am | by Stryker | Articles | Comments

The Stryker Corporation’s highly specialized System 6 power tools, which include high-precision handheld devices such as oscillating bone saws, demand frequent manufacturing requirements for low quantities of these devices. This presents an ongoing challenge for the Production Group’s management team at the company’s main manufacturing location in Kalamazoo. The location is also home to the company’s Experimental Group, which investigates new technologies, advanced materials, and various manufacturing protocols in an effort to maintain optimal productivity for the company. Production Part Approval Process (PPAP) protocols are strategized here as well.

TOPICS:

Pump Provides Optimum Flow Smoothness for Microfluidic Applications

August 25, 2010 7:37 am | The Dolomite Centre Ltd | Product Releases | Comments

Dolomite is dedicated to providing highly optimized equipment for a range of microfluidic applications. The recently launched Mitos P-Pump provides a pulseless liquid flow, using a precise pressure driven pumping mechanism.

Biodel to net $9.4M from stock offering

August 25, 2010 7:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Biodel Inc., a diabetes-focused therapeutics firm in Danbury, Conn., has announced a registered direct offering of almost 2.4 million shares of common stock and warrants to buy the same number of shares, which will bring about $9.4 million to the biotech.

Advertisement

Octagam [Immune Globulin Intravenous (human)] 5 & #37; Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events

August 25, 2010 7:33 am | by U.S. Food & Drug Administration | News | Comments

Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.

Pharmacovigilance Breakthrough: Henry Ford Health System Partners with Rexam and Med Time Technology to Remind Patients to Take Prescription Medication "As Prescribed" to redu...

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

DEARBORN, Mich., Aug. 25 /- A leader in healthcare, Henry Ford Health System will introduce at its hospitals and pharmacies "The Pill Timer," representing a "breakthrough" designed to improve treatment outcomes and reduce adverse drug events often resulting in costly hospital admissions...

TOPICS:

Reportlinker Adds Pharmaceutical M & A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 25 /- Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical M&A in the Asia-Pacific Region – India and China drive regional activity but Japan still dominates high value transactions...

TOPICS:

PharMEDium Elects William R. Spalding to Board of Directors

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Aug. 25 /- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the election of William R. Spalding to the company's Board of Directors. Spalding is Co-founder and Principal of The Crawford Spalding Group, an advisory and management services...

TOPICS:

Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and... -- SHENZHEN, China, Aug. 25 /PRNewswire-Asia-FirstCall/ --

TOPICS:

Kewaunee Scientific Corporation Declares Quarterly Dividend

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

STATESVILLE, N.C., Aug. 25 /- Kewaunee Scientific Corporation (Nasdaq: KEQU ) announced today that its Board of Directors declared a quarterly cash dividend of ten cents per outstanding share, payable on September 23, 2010 to stockholders of record at the close of business on September 9,...

TOPICS:

Physician Referrals Limiting Treatment of the Venous System

August 25, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

TORONTO, Aug. 25 /- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that although venous procedures are set to grow by more than 10% through 2013, a lack of awareness among referring physicians is a major roadblock in increased...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading